TABLE 1.
VARIABLE | EXPERT (N=49) MEAN | NON-EXPERT (N=39) MEAN |
---|---|---|
Comfort level treating patients with HS | ||
Mild disease | 4.62 | 4.39* |
Moderate disease | 4.54 | 4.00** |
Severe disease | 4.23 | 3.16** |
Interest in regularly providing care for HS patients | ||
Mild disease | 4.51 | 3.90 * |
Moderate disease | 4.72 | 3.74 ** |
Severe disease | 4.67 | 3.29 ** |
I would rather refer HS patients with moderate-to-severe disease to another dermatologist | 1.67 | 3.00 ** |
Amount of HS education | ||
Medical School | 1.62 | 1.63 |
Residency | 3.28 | 3.59 |
Residency training provided experience using medical therapies for | ||
Mild disease | 3.82 | 4.23 |
Moderate disease | 3.59 | 3.87 |
Severe disease | 3.21 | 3.17 |
Residency training provided experience using surgical therapies for | ||
Mild disease | 3.18 | 3.50 |
Moderate disease | 2.92 | 2.76 |
Severe disease | 2.67 | 2.21 |
Barriers to becoming an HS expert | ||
Training/education on medical therapies | 2.82 | 2.88 |
Experience with medical therapies | 3.05 | 2.83 |
Training/education on surgical therapies | 3.59 | 4.08 |
Experience with surgical therapies | 3.67 | 4.13 |
Support/mentorship in treating advanced disease | 3.33 | 3.67 |
Insurance coverage/reimbursement for HS treatments | 3.54 | 3.67 |
Clinic logistics (e.g., adjusting schedule for HS appointments) | 3.33 | 3.43 |
Access to equipment (ex: laser) | 3.55 | 3.29 |
Statistical significance of Mann-Whitney U test denoted by
*p<0.05,
**p<0.00063 (Bonferroni-adjusted α)